What is the appropriate method to convert a patient from oral oxycodone 10 mg to oral immediate‑release hydrocodone, accounting for equianalgesic conversion and incomplete cross‑tolerance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Converting from Oxycodone 10 mg to Hydrocodone

Start with hydrocodone 15 mg every 4-6 hours, which represents a 25-50% dose reduction from the equianalgesic dose to account for incomplete cross-tolerance.

Conversion Algorithm

Step 1: Calculate 24-Hour Oxycodone Dose

  • If taking oxycodone 10 mg every 4-6 hours: 40-60 mg/day total
  • If taking 10 mg as a single dose: determine actual 24-hour requirement first

Step 2: Apply Equianalgesic Conversion Ratio

Using the NCCN 2025 equianalgesic table 1:

  • Oral oxycodone 15-20 mg = Oral hydrocodone 30-45 mg
  • This yields approximately a 1:2 ratio (oxycodone:hydrocodone)
  • Therefore, oxycodone 10 mg ≈ hydrocodone 20 mg equianalgesic dose

Step 3: Reduce for Incomplete Cross-Tolerance

Critical safety step: When pain is adequately controlled, reduce the calculated equianalgesic dose by 25-50% 2. This accounts for:

  • Incomplete cross-tolerance between different opioids
  • Individual variability in opioid response
  • Risk mitigation for oversedation and respiratory depression

Calculation for single 10 mg dose conversion:

  • Equianalgesic hydrocodone dose: 20 mg
  • Apply 25% reduction: 20 mg × 0.75 = 15 mg
  • Apply 50% reduction: 20 mg × 0.50 = 10 mg

Start with 10-15 mg hydrocodone every 4-6 hours depending on pain control status.

Step 4: Adjust Based on Pain Control Status

If pain was well-controlled on oxycodone:

  • Use the 50% reduction: Start hydrocodone 10 mg every 4-6 hours
  • This conservative approach minimizes adverse effects

If pain was poorly controlled on oxycodone:

  • Use the 25% reduction: Start hydrocodone 15 mg every 4-6 hours
  • May even use 100% of equianalgesic dose (20 mg) or increase by 25% (25 mg) during first 24 hours 2

Critical Clinical Considerations

Formulation Limitations

Important caveat: Immediate-release hydrocodone is only available commercially combined with acetaminophen (maximum 325 mg per tablet) or ibuprofen 1. You must:

  • Monitor total daily acetaminophen dose (maximum 3,000-4,000 mg/day)
  • Account for the non-opioid component when prescribing
  • Consider hydrocodone ER formulations if available without combination products

Monitoring Requirements

  • First 24-72 hours: Close monitoring for respiratory depression, especially after initiating therapy 3
  • Assess pain control and side effects at each dose
  • Titrate based on individual response, not just conversion calculations

Dosing Frequency

  • Hydrocodone duration of action: 3-5 hours 1
  • Schedule every 4-6 hours for around-the-clock pain control
  • Provide breakthrough doses for incident pain

Common Pitfalls to Avoid

  1. Don't use conversion ratios rigidly: The NCCN explicitly states "equivalence data have not been substantiated" for hydrocodone 1. Clinical experience suggests variability in effective doses.

  2. Don't forget the 25-50% reduction: This is the most critical safety step when switching opioids with adequate pain control 2.

  3. Don't overlook acetaminophen limits: FDA restricts acetaminophen to ≤325 mg per dosage unit in combination products 1. Calculate total daily acetaminophen exposure.

  4. Don't assume 1:1 potency: While some research suggests hydrocodone may be approximately equipotent with morphine 4, the NCCN conversion table indicates hydrocodone is less potent than oxycodone on a mg-per-mg basis 1.

Evidence Quality Note

The conversion ratio between oxycodone and hydrocodone has limited high-quality evidence. The NCCN 2025 guidelines note that hydrocodone equivalence data "have not been substantiated" 1. Research shows significant variability in opioid conversion calculations among clinicians 5, and the evidence base for equianalgesic ratios is relatively weak 6, 7. This underscores the importance of conservative initial dosing with careful titration based on individual patient response.

References

Guideline

adult cancer pain, version 2.2025, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2025

Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Research

Variability in Opioid Equivalence Calculations.

Pain medicine (Malden, Mass.), 2016

Research

Opioid conversions in acute care.

The Annals of pharmacotherapy, 2007

Research

Clinical application of opioid equianalgesic data.

The Clinical journal of pain, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.